IFP Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

IFP Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-384	Closed	-$7K	–	4244
2018 Q1	$7K	Hold	384	–	–	﹤0.01%	3036
2017 Q4	$7K	Sell	384 -532	-58%	-$6.55K	﹤0.01%	3082
2017 Q3	$11K	Hold	916	–	–	﹤0.01%	2996
2017 Q2	$10K	Hold	916	–	–	﹤0.01%	3061
2017 Q1	$10K	Buy	916 +599	+189%	+$6.95K	﹤0.01%	2960
2016 Q4	$4K	Buy	+317	New	+$4.42K	﹤0.01%	3461

IFP Advisors's SCMP Position: Q2 2018 in Review

IFP Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2018, closing a stake of 384 shares — an estimated $7K sold.

IFP Advisors first reported a position in SCMP in Q4 2016 and held it in 6 quarters. The position peaked at $11K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCMP as of Q2 2018.

IFP Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
IFP Advisors sold 384 Sucampo Pharmaceuticals, Inc. shares in Q2 2018, an estimated $7K.
IFP Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 6 quarters.
IFP Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $11K in Q3 2017.
0 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.